These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 32196410)

  • 1. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
    Lin L; Lu L; Cao W; Li T
    Emerg Microbes Infect; 2020 Dec; 9(1):727-732. PubMed ID: 32196410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of lethal human coronaviruses.
    Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
    Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
    İnandıklıoğlu N; Akkoc T
    Adv Exp Med Biol; 2020; 1288():5-12. PubMed ID: 32514817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
    Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
    Sariol A; Perlman S
    Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
    Liu X; Cao W; Li T
    Front Immunol; 2020; 11():1660. PubMed ID: 32760407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
    Rokni M; Ghasemi V; Tavakoli Z
    Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
    Zhang YY; Li BR; Ning BT
    Front Immunol; 2020; 11():2033. PubMed ID: 32922406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Quan C; Li C; Ma H; Li Y; Zhang H
    Clin Microbiol Rev; 2020 Oct; 34(1):. PubMed ID: 33055229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
    Kellam P; Barclay W
    J Gen Virol; 2020 Aug; 101(8):791-797. PubMed ID: 32430094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.
    Díez JM; Romero C; Gajardo R
    Immunotherapy; 2020 Jun; 12(8):571-576. PubMed ID: 32397847
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
    Astuti I; Ysrafil
    Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.
    Ayouba A; Thaurignac G; Morquin D; Tuaillon E; Raulino R; Nkuba A; Lacroix A; Vidal N; Foulongne V; Le Moing V; Reynes J; Delaporte E; Peeters M
    J Clin Virol; 2020 Aug; 129():104521. PubMed ID: 32623350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.